Profile

Eric J. Chow, MD, MPH

Eric J. Chow, MD, MPH

"My goal is not just to improve cure rates for childhood cancer, but to improve the quality of life for children and families dealing with and successfully overcoming cancer."

Eric Chow, MD, MPH, is an attending physician at Seattle Childrens Hospital, assistant professor of pediatrics at the University of Washington School of Medicine, and a member of the Clinical Research and Public Health Sciences Divisions at the Fred Hutchinson Cancer Research Center. His clinical and research interests focus on cancer survivorship, and he is the medical director of the childhood cancer survivor program at Seattle Childrens.

Together with other members of the Cancer and Blood Disorders Center, the goal of the cancer survivor program is to enhance patient and family awareness of potential cancer therapy-related late effects, and to maximize quality of life by early detection and treatment of these late effects. Dr. Chow's current research attempts to better understand risk factors that contribute to increased metabolic and cardiovascular complications following cancer therapy, with studies examining glucocorticoid pharmacogenetics in relation to obesity following leukemia therapy, treatment and genetic factors that contribute to cardiovascular toxicity following hematopoietic cell transplantation, and application of population-based databases to study cancer late effects. Related to these interests, Dr. Chow holds leadership positions within the Childrens Oncology Groups Outcomes and Survivorship Committee and the National Cancer Institute sponsored Childhood Cancer Survivor Study.

Making A Difference

Recommendations

DebbieBellingham, WA10.02.11

Dr. Chow is terrific at communicating honestly & medically in a way that is easy to understand during a very difficult time. I found Dr. Chow passionate & earnest in caring for the children on the hem/onc floor. And as a mother of a child who underwent cancer treatment at Seattle Children's, I always felt a greater sense of comfort knowing we were in the care of Dr. Chow.

I am a pediatric oncologist whose research focuses on cancer survivorship. My group is interested in better understanding the burden and risk factors for various endocrine/metabolic (e.g. obesity, insulin resistance) and cardiovascular outcomes following childhood cancer therapy. To this end, we utilize data from medical records as well as prospectively bring patients back to clinic for various physiologic measurements. Our survivorship research also includes work examining various gene polymorphisms of interest and data linkage strategies utilizing state administrative databases.

Increased cardiometabolic traits in pediatric survivors of
acute lymphoblastic leukemia treated with total body
irradiation.Biology of blood and marrow transplantation :
journal of the American Society for Blood and Marrow
Transplantation
, 2010 May 31

The Childhood Cancer Survivor Study: a National Cancer
Institute-supported resource for outcome and intervention
research.Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2009 May 10
: 2308-18

Chronic disease in the Childhood Cancer Survivor Study
cohort: a review of published findings.Journal of clinical oncology : official journal
of the American Society of Clinical Oncology
, 2009 May 10
: 2339-55

Childhood cancer among twins and higher order
multiples.Cancer epidemiology, biomarkers &
prevention : a publication of the American Association for Cancer
Research, cosponsored by the American Society of Preventive
Oncology
, 2009 Jan.
: 162-8

What's New

About This Site

Seattle Children’s provides healthcare without regard to race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry) or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.